NASP Comments to CMS on Part B Drug Proposal

NASP comments on the organization’s concerns over the CMS proposed plan.

©2016 National Association of Specialty Pharmacy
300 New Jersey Avenue NW, Suite 900
Washington, D.C. 20001
703.842.0122